NCT06825715 · VA Office of Research and Development
Multilevel Intervention for Precision Oncology
(MIPO)
What this study is about
The investigators are rolling out a 3 level intervention designed to improve the use of Precision Oncology at 8 VA medical centers.
View original scientific description
The investigators are rolling out a 3 level intervention designed to improve the use of Precision Oncology at 8 VA medical centers. The 3 components of the intervention are 1: a short educational video for patients, 2: audit and feedback to providers on their Precision Oncology practice patterns, and 3: a change in the electronic medical record to make it easier to order and review results of Precision Oncology tests.
Interventions
OTHER
Multilevel intervention
3 components: patient education video, provider audit/feedback, and EMR ordering change
Primary outcome measures
Use of molecular testing
Time frame: 3 years
Proportion of eligible patients with lung and prostate cancer who have next generation sequencing molecular testing
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Patients in the VA with cancer of the lung or prostate who are seen in the oncology clinic
Exclusion criteria
- Cancer that did not originate in the prostate or the lung
Where
- New York, New York
Collaborators
VA Madison Health Care, VA Pittsburgh Healthcare System, Martinsburg VA Medical Center, VA Eastern Oklahoma Health Care, New Orleans VA Medical Center, Northport VA Medical Center, Fargo VA Medical Center
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jul 7, 2026 · Source of record for eligibility and locations